MycoBiomDB – Record Details (MyCo_1060)

Biomarker Record Details

Database ID: MyCo_1060
DB IDMyCo_1060
TitleThe role of basophil activation test in allergic bronchopulmonary aspergillosis and Aspergillus fumigatus sensitization in cystic fibrosis patients
Year2016
PMID26922860
Fungal Diseases involvedAllergic bronchopulmonary aspergillosis
Associated Medical ConditionCystic fibrosis
GenusAspergillus
Speciesfumigatus
OrganismAspergillus fumigatus
Ethical StatementThe study was approved by The Ethical Committee of “Aghia Sophia” Children's Hospital and patients or parents for the minors provided their informed consent before enrollment in the study.
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceBlood
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameCD203c
Biomarker Full NameCD203c
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationGreece
CohortThe CF center of “Aghia Sophia” Children's Hospital provides care to more than 400 CF patients. Diagnosis of CF was confirmed by sweat chloride levels (N 60 mmol/L by quantitative pilocarpine iontophoresis) and genotyping. BAT (CD63 and CD203c) was performed in 17 CF patients with ABPA diagnosis, 24 CF patients with AFS and 15 non-AFS CF patients.
Cohort No.56
Age GroupNone
P Valuep<0.001
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
TechniqueAnalytic
Analysis MethodFastimmune™ Kit (BD Biosciences, San Jose, California, USA) , Basotest® Kit (Orpegen Pharma, Heidelberg, Germany), Allergenicity Kit (Beckman Coulter Immunotech, Marseille, France)
ELISA kitsFastimmune™ Kit (BD Biosciences, San Jose, California, USA) , Basotest® Kit (Orpegen Pharma, Heidelberg, Germany), Allergenicity Kit (Beckman Coulter Immunotech, Marseille, France)
Assay DataNone
Validation Techniques usedBasophil activation test
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone